An Incisive, In-depth Analysis on the Human Milk Oligosaccharides Market
This study offers a comprehensive, 360 degree analysis on the Human Milk Oligosaccharides market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Human Milk Oligosaccharides market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Increasing demand for infant nutrition products anticipated to boost the global human milk oligosaccharides market
Infant formula ingredients such as human milk oligosaccharides have been gaining popularity in the recent past as an infant formula ingredient to cater to the demands of the baby nutrition segment. Health benefits associated with the consumption of human milk oligosaccharides include maintaining gut microbiota and inhibition of pathogen in infants. These are factors likely to drive the growth of the global human milk oligosaccharides market. Human milk oligosaccharides are gaining traction due to the potential benefits by consumption such as a prebiotic to maintain a healthy immune system in infants. It also aids in blocking adhesion of microbial pathogens and foreign particles to epithelial surfaces, thus improving gut colonisation.
Human milk oligosaccharides (HMO) is a better alternative for non-lactating mothers as it has all the nutrients required by infants for normal growth. Manufacturers are producing HMOs by various chemical synthesis and fermentation processes in order to cater to the demand for infant formula ingredients. According to the WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and reach 9.5 billion by 2050. The constantly growing population is likely to increase demand for infant nutrition products. The demand for infant formula is significantly high in China as well as in certain countries in the Asia Pacific owing to a high infant population.
High prices owing to costly chemical synthesis and the presence of substitutes with the same potential and functional benefits are hampering the growth of the global human milk oligosaccharides market
Human milk oligosaccharides are the third largest component of human milk, but cannot be synthesised directly through human milk due to low availability of a donor group. Currently, manufacturers are developing technologies to produce human milk oligosaccharides through chemical and enzymatic synthesis. These synthetic and enzymatic methods require high capital and resources, but the final product produced is in relatively low quantity. For instance, enzymatic synthesis is required for costly substrates such as glycosyltransferases and this is one of the major factors attributed to the high price of human milk oligosaccharides.
Infant formula ingredients such as galactooligosaccharides and fructooligosaccharides are used as prebiotics in infant formula to reduce the growth of pathogenic Escherichiacoli. Consumption of these offers health benefits for the gastrointestinal tract of infants by stimulating the growth of selected micro-organisms in intestinal microflora. Manufacturers of infant formula are using these as substitutes to human milk oligosaccharides due to the low cost and high availability. Hence, these alternatives to human milk oligosaccharides with the same functional benefits is restricting the growth of the overall market to a large extent.
Fucosyllactose segment is the largest segment with close to 50% market share in the global human milk oligosaccharides market
Among the various product type segments, the fucosyllactose segment is estimated to account for a market share of almost 48% in terms of value, followed by the sialyllactose segment with a value share of around 28% by 2017 end. The fucosyllactose product type segment is estimated to be valued at more than US$ 9 Mn by the end of 2017 and is projected to increase at a CAGR of 14.4% over the period of assessment. On the other hand, the sialyllactose segment is estimated to be valued at more than US$ 5 Mn by the end of 2017 and is anticipated to increase at a CAGR of 15.1% over the forecast period and be valued at more than US$ 20 Mn by the end of 2027.
Asia Pacific is expected to be a key market in the global human milk oligosaccharides market. Due to increasing awareness among consumers regarding infant nutrition and increasing population, demand for 2-fucosyllactose as the solution for infant nutritional care is expected to be high in countries such as India and China. Furthermore, new end-use companies are also surfacing in the region. Human milk oligosaccharides manufacturing companies are focussing on investing in research and development for developing a variety of human milk oligosaccharides for application as an ingredient in infant formulas. In a new report titled “Human Milk Oligosaccharides Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” Future Market Insights presents deep insights into the global human milk oligosaccharides market over a 10 year forecast period. According to the report findings, an increasing demand for functional food and beverage products owing to increasing awareness among consumers about the health benefits from consumption of such products is a factor expected to drive growth in terms of value of the human milk oligosaccharides market over the forecast period. This increasing demand is prompting manufacturers to produce ingredients such as human milk oligosaccharides for application in functional food and beverages.
The global human milk oligosaccharides market report begins with the definition, relevance and impact of forecast factors used to estimate the global human milk oligosaccharides market values. It is followed by an overview of the key market dynamics of the global human milk oligosaccharides market, which includes Future Market Insights’ analysis of key trends, drivers, restraints and opportunities that are influencing the development of the global human milk oligosaccharides market. Impact analysis of key growth drivers and restraints based on the weighted average model has been included at a regional level in the global market report after a detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the global human milk oligosaccharides market.
Macro-economic indicators such as infant nutrition industry outlook, food and health supplement spending and others have been considered to arrive at the indicated market numbers. Bottom-up approach has been used to counter validate the reached numbers for segment type market numbers, while top-down approach has been used to assess market numbers for each segment. In the final section of the report on the global human milk oligosaccharides market, detailed profiles of vendors in the market have been included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global human milk oligosaccharides market.
By Product Type
In-depth secondary research has been leveraged to arrive at the overall market size, top industry players, top products and industry associations. In order to conduct expert and industry interviews, Future Market Insights has formulated a detailed discussion guide. To make this report an exclusive one, a list of industry players including manufacturers, distributors, retailers and industry experts has been developed and our analysts have conducted detailed interviews with key stakeholders in the global human milk oligosaccharides market to present a crystal clear picture of the market. Data is validated using the triangulation method in which secondary and primary research data along with Future Market Insights’ analysis contribute to the final data.